Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > On GLP-1 agonists US Senate passes anti-patent thicket bill

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jul 18, 2024 8:14am

62 Views

Post# 36137978

RE:RE:RE:RE:RE:RE:RE:RE:RE:On GLP-1 agonists US Senate passes anti-patent thicket bill

The Dems don't care what happens to Biden....all they care about is power....who is Peter Thiels?.....btw, JD Vance is an ex Marine.....he ain't anyone's "boy"....but go ahead and try to trash him.....the Dem's can't run on any policy successes, so all they have is insulting Republicans...

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting